Entrada Therapeutics shares owned by Moore Capital Management
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Moore Capital Management
from 13F filings
Historical chart of Moore Capital Management investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Entrada Therapeutics by Moore Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $1.5M | 105k | 14.25 |
2024-03-31 | $1.5M | 105k | 14.17 |
2023-12-31 | $1.6M | 105k | 15.09 |
2023-09-30 | $1.7M | 105k | 15.80 |
2023-06-30 | $1.6M | 105k | 15.14 |
2023-03-31 | $1.5M | 105k | 14.50 |
2022-12-31 | $1.4M | 105k | 13.52 |
2022-09-30 | $1.7M | 105k | 15.76 |
2022-06-30 | $1.3M | 105k | 12.18 |
2022-03-31 | $986k | 105k | 9.39 |
2021-12-31 | $1.8M | 105k | 17.12 |